D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CKPT holding history
Checkpoint Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CKPT overviewAll 13F holders of CKPTFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −29,695−100.0% | Sold out | Holders |
| Q4 2024 | 29,695 | $95.0K | <0.1% | −58,727−66.4% | Reduced | Holders |
| Q3 2024 | 88,422 | $198.1K | <0.1% | +42,468+92.4% | Added | Holders |
| Q2 2024 | 45,954 | $98.8K | <0.1% | −62,658−57.7% | Reduced | Holders |
| Q1 2024 | 108,612 | $222.7K | <0.1% | −31,934−22.7% | Reduced | Holders |
| Q4 2023 | 140,546 | $321.9K | <0.1% | +140,546 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −1,076−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q3 2022 | 10,756 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 10,756 | $11.0K | <0.1% | −5,813−35.1% | Reduced | Holders |
| Q1 2022 | 16,569 | $29.0K | <0.1% | −101,755−86.0% | Reduced | Holders |
| Q4 2021 | 118,324 | $368.0K | <0.1% | +48,694+69.9% | Added | Holders |
| Q3 2021 | 69,630 | $230.0K | <0.1% | −21,116−23.3% | Reduced | Holders |
| Q2 2021 | 90,746 | $268.0K | <0.1% | +90,746 | New | Holders |